Armata Pharmaceuticals Inc

Armata Pharmaceuticals Inc

ARMP

Get informed when a big investor buys or sells

+ Follow
Market Cap$137.3M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Armata Pharmaceuticals IncArmata Pharmaceuticals Inc-0.7-83%--0.5
$-10.87

Current Fair Value

402.8% downside

Overvalued by 402.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$137.30 Million
Enterprise Value$221.37 Million
Dividend Yield$- (-)
Earnings per Share$-4.8
Beta1.35
Outstanding Shares36,747,840

Return

Return on Equity83.13%ROE
Return on Assets-213.65%
Return on Invested Capital-35.06%

Valuation & Multiples

P/E Ratio-0.71P/E Ratio
PEG0.13PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.51Price to Book Ratio
Enterprise Value to Revenue50.5
Enterprise Value to EBIT3.94
Enterprise Value to Net Income-2
Total Debt to Enterprise0.49
Debt to Equity-0.47Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 18, 2026
EPS Estimate
$-0.39
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
November 11, 2026
EPS Estimate
$-0.57
Average shareholder expectation
Revenue Estimate
$450,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %13.64%▲ 2.89%
Total Invested$32.47M▼ 19.25%
Investors Holding54▲ 9.00%

ESG Score

No data

About Armata Pharmaceuticals Inc

CEO: Todd Patrick